People
Synthetic biology – an engineering approach to biological science– is gaining traction in biotechnology worldwide.
A Chinese scientist living abroad who has been accused of accepting stolen intellectual property to benefit a pharma startup in China has been extradited to the United States.
Biocon Ltd,, an innovation-led global biopharmaceuticals company, announced that it has appointed Mr. M.B. Chinappa as Chief Financial Officer of its subsidiary Biocon Biologics India Ltd.
BioSpace spoke to leaders from various corners of the industry who provided their insights into what the coming year is likely to hold for their particular sphere.
Pharma, biotech and life sciences companies boost their leadership ranks with this weeks Movers & Shakers.
“We are Earth’s Tech Support,” declared Randall Kirk, Executive Chairman of the Board of Directors and former CEO of Intrexon. His company is one of the biggest developers of synthetic biology (or engineering biology) applications in therapeutics, agriculture and chemicals.
The company is changing its name to Precigen, Inc. and tapped Helen Sabzevari as its new president and chief executive officer.
There were a number of scandals in the biopharma industry that caught our attention in 2019. Here’s a look at four of them.
Cerecin, an innovative biopharmaceutical company focused on brain health, announced that Joseph S. Zakrzewski has joined the Company’s Board of Directors as Chairman.
Zelluna Immunotherapy announces the appointment of Namir Hassan as chief executive officer.
PRESS RELEASES